WaveFront Dynamics, an Albuquerque, N.M.-based early stage ophthalmic medical device company, held the first close of a $3m Series A financing round.
The round was led by new investor Tramway Venture Partners LP and included investments from a Phoenix Venture Partners LP affiliate and an additional angel investor. In connection with the financing, Waneta Tuttle of Tramway Venture Partners and Frank Levinson of Phoenix Venture Partners will join WaveDyn’s Board of Directors.
The funds will support continued development of its ophthalmic measurement device with dynamic wavefront technology and subsequent clinical studies.
Led by Founder and CEO Dan Neal, PhD, an optical scientist with the vision to develop novel methods to assess the visual performance of the human eye, WaveDyn is developing proprietary methods to measure changes of the eye dynamically, over a sequence in time, rather than a single snapshot. The company will leverage its dynamic wavefront measurement capabilities to create ophthalmic treatment solutions for patients with complex visual dysfunction.